Human acid sphingomyelinase (ASM) 
INTRODUCTION
potentially play a role in signal transduction. The discovery that regulation of cell differentiation and proliferation directly Human acid sphingomyelinase (ASM; EC 3.1.4.12) is a lysodepends on the levels of ceramide, ceramide 1-phosphate and somal glycoprotein which hydrolyses sphingomyelin to ceramide certain sphingoid bases in the cell triggered studies on sphingoand phosphocholine. Since it became clear that an inborn error myelin turnover. Further evidence of highly regulated sphingoof sphingomyelin metabolism, known as Niemann-Pick disease, myelin catabolism suggests a pivotal role for sphingomyelinase is caused by autosomal recessive deficiency of this enzyme (Brady in the 'sphingomyelin cycle'. Degradation of sphingomyelin was et al., 1966) , several groups have attempted to isolate it.
found to occur in response to various cellular signals, such as Purification procedures starting from human placenta, spleen, tumour necrosis factor a, interleukin-1 and interferons (Mathias brain and urine yielded inhomogeneous preparations of different Dobrowsky and Hannun, 1992) . Moreover, recent sizes as well as widely diverging specific activities (Jones et al., findings indicate that an ASM besides the neutral sphingo-1981; Yamanaka and Suzuki, 1982; Sakuragawa, 1982; myelinase, which has also been discussed as a potential ceramideal., 1985) . This broad heterogeneity of apparently pure enzymes, releasing enzyme, may be involved in this regulatory pathway ranging from 30 kDa up to 90 kDa, and the proposal of several which is proposed to be a cascade induced by tumour necrosis potential subunits contributing to active enzyme complexes, has factor a acting by receptor-mediated stimulation of phosphaled to controversy over the past 10 years. Thus far, reports on tidylcholine-specific phospholipase C (Schutze et al., 1992) . enzyme-specific antibodies and provisional biosynthetic studies Released 1,2-diacylglycerol is postulated to activate sphingohave not led to unequivocal experiments (Rousson et al., 1987;  myelinase under acidic conditions leading to elevated intra- Jobb and Callahan, 1989) . In 1987 we finally succeeded in cellular levels of ceramide which finally activate nuclear factor purifying ASM to homogeneity from the urine of patients KB via ceramide-specific kinases. Intriguingly, pure human seriously affected by peritonitis, traumata or postcardiac surgery ASM, the only sphingomyelin-specific acidic lipase characterized (Quintern et al., 1989a) . This preparation yielded a monomeric so far, has previously been shown to be significantly stimulated glycoprotein about 70 kDa in size with a specific enzyme activity by 1,2-diacylglycerol (Quintern et al., 1989a) , thus pointing to a of 2.5 mmol/h per mg at pH 5.0. Amino acid sequencing led to close relationship, if not identity, between ASM and the enzyme isolation of three alternatively spliced cDNA species and ininvolved in this postulated sphingomyelin cycle. Therefore we formation about the organization of the corresponding gene raised appropriate anti-ASM antibodies in order to analyse (Quintern et al., 1989b; Schuchman et al., 1991 Schuchman et al., , 1992 . The further the biosynthesis and processing of this enzyme, its above data have been used as the basis for various mutation subcellular localization and targeting. studies on mRNA and genomic DNA from cells of patients with Niemann-Pick disease (Levran et al., 1991a,b; Ferlinz et al., EXPERIMENTAL 1991; Takahashi et al., 1992; Vanier et al., 1993 Expression of ASM protein in E. coli and Immunization of rabbits
The full-length cDNA of ASM except the portion containing the signal peptide was cloned into the prokaryotic expression vector pQE (Diagen). Expression of the corresponding cDNA construct yielded a fusion protein consisting of six N-terminal histidine residues followed by two additional amino acids derived from sequences of the cloning site and the ASM amino acid sequence representing the mature protein from residue 47 to 629. Purification of the fusion protein was easily achieved by nickel ion chelating chromatography (Hochuli et al., 1988 (Kaufman, 1985) (designated wild-type ASM) was used to generate all mutagenized constructs discussed in this study (see Figure 5 ). The /J ASM construct lacking both natural ATGs and the DNA region encoding the endoplasmic reticulum (ER) import signal was generated by PCR amplification of wild-type cDNA using a sense primer downstream of this sequence containing a 5'-flanking EcoRI site as well as an artificial ATG for translation initiation (3lsig) and the antisense primer N2. Construction of the mutant vector was also performed by transfer of a mutagenized EcoRI-CelII cassette.
y ASM containing a single base insertion between the first and second in-frame ATG was generated by PCR amplification of wild-type DNA using the frameshift oligonucleotide ylfs and the antisense primer N2. The final vector y ASM was constructed as described above. Standard procedures for molecular cloning were performed as described by Sambrook et al. (1989) . All PCR-mutagenized sequences as well as DNA portions flanking the cloning sites were verified by the Sanger dideoxy-chaintermination method (Sanger et al., 1977) .
Cell culture, transfection of COS-1 cells and ASM assay
About 5 x 105 COS-1 cells supplemented with Dulbecco's modified Eagle's medium (DMEM) and 10 % fetal calf serum (FCS) were plated on 6 cm dishes the day before transfection. The standard liposome-mediated transfections with DOTAP were carried out using 7 ,ug of pure DNA for each dish. During this 6 h period the cells were maintained in OptiMEM (Gibco-BRL) medium without supplements. At 48 h after transfection, the cells were harvested and assayed for ASM activity using [3H]choline-labelled sphingomyelin as described elsewhere (Quintern et al., 1987) or were plated on to coverslips for fluorescence microscopy.
Metabolic labelling and immunoprecipitation
About 48 h after transfection, COS-1 cells (21 cm2 culture dishes) were starved for 1 h in 1 ml of methionine-free MEM containing 4 % dialysed and heat-inactivated FCS. After 1 h, 100 ,uCi of L-[35S]methionine (Amersham) was added and cells were labelled for the times indicated. The chase periods were started by the addition of unlabelled methionine (final concentration 100 ,M). Experiments using brefeldin A were performed by adding the drug to a final concentration of 1 jtg/ml to the culture medium 1 h before methionine starvation. Incubation with brefeldin A was continued throughout pulse and chase periods. The labelled COS-1 cells were rinsed once with Tris-buffered saline (TBS), harvested by scraping off the culture dishes and lysed in 0.5 ml of TBS buffer containing 1% Nonidet P40, 10 mM EDTA, 2 mM phenylmethanesulphonyl fluoride, 1 mM pepstatin and 1 mM leupeptin. For phosphate labelling, pyrophosphate, NaF and orthovanadate at final concentrations of 10, 5 and 1 mM respectively were added.
Cell extracts and media were preabsorbed with 10,l of preimmune rabbit serum and 30 m1l of a 50 % (w/v) suspension of Protein A-Sepharose for 3 h. Immunocomplexes were removed by centrifugation at 300 g for 5 min.
The preabsorbed homogenates and media were centrifuged at 100000 g for 1 h in a Beckman Ti75 rotor. The supernatants were carefully removed and 2 ,ul of anti-ASM serum was added. They were then incubated for 12 h at 4 'C. Immunoprecipitation was carried out in the presence of 15,l of Protein A-Sepharose
Maturation of human acid sphingomyelinase (50 % suspension) for 2 h. Immunocomplexes were treated as described (Schnabel et al., 1992) . Deglycosylation with EndoF (New England Biolabs) was performed according to the manufacturer's instructions.
Isoelectric focusing
COS-1 cells were transfected in the presence of [35S]methionine during an 8 h pulse period. To analyse enzyme activity in culture medium, cells had to be grown without serum. Isoelectric focusing was performed in focusing columns with a gradient from pH 3 to 10 stabilized in a 0-35 % (w/v) sucrose gradient as described previously (Quintern et al., 1989a) .
SDS/PAGE and autoradlography PAGE was carried out under reducing conditions using 0.75 mm slab gels containing 10 % acrylamide. The gels were fixed in 10 % acetic acid/20 % propan-2-ol for 30 min and impregnated with Amplify (Amersham) before vacuum drying. Fluorography was performed using Kodak X-Omat AR films.
Immunofluorescence studies (Figure 1) . Deglycosylation of these proteins with f,- Figure  4 ). Most ASM activity in the homogenate could be assigned to fractions containing proteins of isoelectric point (pI) 6.8-7.2, whereas a minor portion comprising about 10 % of total enzyme activity peaked around pl 5.0. Immunoreactive material from cell-homogenate-derived isoelectric-focusing fractions was separated by SDS/PAGE and further visualized by fluorography (Figure 4a ). Correlation of catalytic activity with precipitable proteins suggests that mature lysosomal ASM (70 kDa) was restricted to fractions of pH 6.8-7.2. The major proportion of the 57 kDa form could be isolated from fractions of pH 4.8-5.0. Interestingly, ASM precursor (72 kDa) which was spread over the entire pH range (3-8) did not coincide with distinct fractions of ASM activity, implying that this protein exhibits low, if any, enzyme activity. Analysis of the corresponding medium revealed two molecular forms of ASM, the secretory form of the ASM precursor (75 kDa) and the small 57 kDa form (Figure 4b ). Determination of activity revealed some, but low, sphingomyelin degradation in fractions of pH 4.8-5.0 which again correlated with a faint band of 57 kDa ASM. The medium from mocktransfected COS-1 cells did not show any ASM activity.
As both enzymically active forms of ASM are of potential physiological significance, the question arose whether 57 kDa ASM originates from early proteolytic cleavage of a common precursor or as the result of different translation-initiation sites of the corresponding gene. Therefore we analysed the functionality of the two possible in-frame initiation codons (AUGs) as well as the DNA region encoding the potential ER import signal sequence responsible for biosynthesis and proper targeting by expressing human ASM cDNA (wt ASM) mutagenized at appropriate sites ( Figure 5 ). Enzymic studies on COS-1 cells transfected with either wildtype or mutant cDNAs indicated that wild-type cDNA (wt ASM) and a ASM, which lacks the first ATG, expressed enzymically active proteins to a similar extent ( Table 2) . Insertion of a frameshift between the two potential initiation codons (y ASM) did not result in elevated levels of ASM activity compared with mock-transfected cells. Similarly to y ASM expression, the mutant cDNA lacking the region encoding the signal peptide (ft ASM) also failed to produce catalytically active ASM (Table 2) .
Metabolic labelling of the transfectants followed by immunoprecipitation was performed to visualize the presence of crossreactive material derived from the various mutagenized cDNA constructs (Figure 6 ). COS-1 cells transfected with either wildtype ASM or a ASM synthesized almost identical amounts of ASM precursor as well as the 57 kDa form. Transfection with y ASM failed to induce expression of significant amounts of immunoreactive protein, implying that the translation product from the first AUG.after introduction of a frameshift mutation has no sequence similarity with the wild-type protein and that the second AUG is not used for translation when the first AUG is present ( Figure 6 ). In the absence of the first AUG, the second AUG can be an effective initiator.
Only one major protein with a reduced molecular size of approximately 60 kDa was detected by the antibodies in ASM transfectants. As expected, this protein, which is missing the signal peptide, is not imported into the ER lumen; it is not glycosylated and thus cannot be transported by a regular vesicular mechanism ( Figure 6 ).
To investigate further whether peptides derived from mutagenized vector constructs are transported and distributed similarly to the wild-type protein, transfected COS-l cells were analysed by indirect immunofluorescence microscopy. Normal and a ASM-derived polypeptides were detected throughout the vacuolar apparatus of the cell. Strong fluorescence staining of compartments representing ER and Golgi is presumably due to enormous overexpression of ASM in transfected cells (Figure 7) . The y-ASM-transfected COS cells completely failed to express cross-reactive protein, whereas fluorescence staining of ASM transfectants-revealed fliorescence exclusively in the cytosol, indicating the pivotat role, of thJe potential signal sequence for luminal ER translocatio"n.
DISCUSSION
As production of mono-and poly-clonal antisera raised against native human ASM from various tissues by several groups failed in terms of specificity of the resulting immunoglobulins (Freeman et al., 1984; Weitz et al., 1985; Maehira and Takaesu, 1987; Rousson et al., 1987) , we decided to overproduce in E. coli a carbohydrate-free recombinant polypeptide chain containing the entire protein core except the potential signal peptide. Standard immunization of rabbits finally led to the first specific polyclonal anti-ASM antibody preparation reported so far which is insensitive to high concentrations of non-ionic detergent. The antiserum specificity recognizes native human enzyme and is capable of precipitating more than 90 % of total ASM activity from crude cell extracts of human tissues. The 10 % remaining may be the result of unfavourable protein conformations, masking of the polypeptide chain by N-glycosylation at the six potentially available sites of the native enzyme or aggregate formation.
Initial biosynthesis studies on human fibroblasts revealed a complex protein pattern consisting of several components of different size. As the pure human urinary enzyme has been exclusively characterized as a glycosylated protein of about 70 kDa, the presence of further protein components was not expected. However, these data support previous reports considering two distinct co-purified ASM-related proteins, a 72 kDa and 54-57 kDa component of undefined origin, which were detected by Western-blot analysis using monoclonal antibodies against protein derived from human placenta . Analysis of ASM from cDNA-transfected COS-l cells, performed to verify the specificity of the antiserum, resulted in detection of proteins similar in size to those from cultured fibroblasts, indicating that they originate from expression of a single mRNA species. In order to analyse the functions of these forms, COS-I cells were wild-type and mock-transfected in the presence of [35S]methionine and cell homogenate as well as media were separated by isoelectric focusing. It should be noted that ASM activity from crude cell extracts was found earlier to peak at at least two distinct isoelectric points, comparable to those in our studies (Callahan et al., 1978; Rousson et al., 1983; Quintern et al., 1989a) . So far, correlation of these data with distinct processing forms of ASM have failed because of the lack of suitable antibodies. Our experiments suggest stepwise and compartment-specific processing and presumably activation of a common primary translation product of molecular mass 75 kDa (Figure 8 ). Early proteolytic cleavage of the preproform into a 72 kDa ASM precursor may reflect removal of the signal peptide which is calculated to be about 4 kDa in size. However, none of these forms was found to express significant enzyme activity. Similar observations were made in studies with cultured I-cell fibroblasts that lacked regular lysosomal sorting by a mannose-6-phosphate-mediated pathway. Although they were shown to secrete most of the newly synthesized ASM precursor, enzyme activity in the respective culture medium was only slightly increased compared with that in control cells (Klaus Ferlinz, In order to verify that the 57 kDa ASM is a product of early proteolytic cleavage and is not the result of the use of different translation-initiation sites on the corresponding gene, ASM cDNA was mutagenized at appropriate sites. Translation of alternatively spliced mRNAs could be excluded, as studies were performed using wild-type cDNA constructs .
The theory of translation initiation of proteins implies that initiation is almost exclusively mediated by the AUG codon located most 5' on the mRNA. In this 'scanning model', the 40S ribosome, together with other translation-initiation factors, binds to the capped terminus of the mRNA and advances until the first AUG is encountered (Kozak, 1989) . Furthermore, the nucleotides surrounding the AUG ofinterest correlate with the efficiency of translation initiation and finally commit the ribosomes to initiate peptide synthesis and elongation until a stop codon is reached. Thus expression of two or more polypeptides originating from different initiation codons usually requires different 5'-truncated mRNA forms which might be generated by promoter switching or alternative splicing of common heterogeneous nRNAs.
Northern-blot analysis as well as primer-extension experiments on the mRNA of ASM provided evidence that the cell transcripts are close in size to that of the full-length cDNA sequence. The majority of mRNA which is 5'-extended for about 100 bases of known cDNA does not contain any further AUG (K. Ferlinz, R. Hurwitz, G. Vielhaber, K. Suzuki and K. Sandhoff, unpublished work). These experiments suggest an untranslated 5'-sequence of about 180 bp which is in agreement with sequences expected from vertebrate mRNAs (Kozak, 1987) .
Our experiments demonstrate that the first of two potential inframe AUGs upstream of the signal-sequence-encoding portion is exclusively used for efficient translation initiation in vivo and that the use of any other potential downstream AUGs can be excluded. Direct evidence confirming this fact came from the transfection of cDNA constructs containing a single base insertion between the two potential initiation codons. Translation of the corresponding mRNAs in transfected COS cells failed to produce enzymically active and immunoreactive peptides. We AUG in the mutant mRNA and proceeded through the frameshift insertion until a stop codon prevented further translation. This presumably resulted in a peptide of 48 amino acid residues in length with obviously no sequence similarity to the native polypeptide and therefore not immunoprecipitated by the antiserum. Results similar to those for ASM were obtained for the ,-chain of hexosaminidases and fl-glucocerebrosidase, for which only the first in-frame AUG was utilized for translation initiation in vivo (Sorge et al., 1987; Sonderfeld-Fresko and Proia, 1988; Neote et al., 1990) . Biosynthesis and processing of recombinant sphingomyelinase starting from the second potential AUG, which we presume to be identical with that in the wild-type protein, indicates that even the loss of a functional primary initiation codon would not result in pathological enzyme deficiency.
A signal sequence responsible for ER import of nascent ASM polypeptides which comprises the N-terminus of the propeptide was postulated by hydrophobicity and secondary-structure analysis of cDNA data as outlined by Garnier et al. (1978) . The authenticity of the predicted sequence was evaluated by expression of the respective cDNA constructs. Proteins lacking the signal sequence were shown to be located cytosolically because transduction into the ER lumen was prevented.
The data presented here clearly establish that the three forms of ASM are generated from the same nascent polypeptide derived from a single processed transcript. These data alone, however, cannot define the position of the 57 kDa form within the 75 kDa form nor can they prove that the 72 kDa form results from removal of the signal peptide from the 75 kDa form. The precise information would require sequencing of all these forms. However, we do have data to indicate that the 57 kDa form is generated largely by cleavage of the N-terminus of the 75 kDa form. When the first two glycosylation sites were eliminated by site-directed mutagenesis and the protein expressed, the normal 75 and 72 kDa forms decreased to sizes expected if the two carbohydrate chains were missing whereas the size of the 57 kDa form remained unchanged (K. Ferlinz, R. Hurwitz, G. Vielhaber, K. Suzuki and K. Sandhoff, unpublished work). This observation clearly indicates that the 57 kDa form does not include the first two glycosylation sites. If the N-terminus is cleaved at or immediately after the second glycosylation site, the remainder should have a sugar-free size of approximately 50 kDa. As there are four glycosylation sites within the remaining C-terminus, this segment will generate a protein of 57-58 kDa when fully glycosylated. Thus the N-terminus of the 57 kDa form must be close to the second glycosylation site and, if C-terminus trimming is involved at all, it cannot be extensive. This information also makes it possible to generate the large-form-specific antibody by using the segment of the larger forms between the N-terminus and the second glycosylation site.
In conclusion, processing of human ASM precursor, which expresses low, if any, catalytic activity, results in two distinct polypeptides. One of these is already generated by proteolytic cleavage inside the ER/Golgi complex whereas the predominant mature 70 kDa form is exclusively processed after sorting for the endosomal/lysosomal pathway. At present it is not clear whether both forms of mature ASM finally reach the lysosomal compartments or whether they have distinct biochemical functions. The fact that the 57 kDa protein obviously does not contain oligomannosyl-linked phosphate residues may point to a different method of sorting, as expected for regular soluble lysosomal proteins. Furthermore, detection of variable relative amounts of cellular 57 kDa ASM implies that activation of the enzyme early on inside the ER and Golgi compartments may be achieved by suggest that protein biosynthesis started solely from the first certain regulated proteases which trigger early processing events.
